Skip to content

    Biofrontera (BFRI) stock price & financials

    View BFRI earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+84.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $9.01M
    $12.56M
    $8.59M
    $9.03M
    $6.99M
    -22.5%
    $17.10M
    +36.2%
    $10.08M
    +17.4%
    $12.00M
    +32.9%
    Strengthening
    Operating Profit
    -$4.96M
    -$1.71M
    -$4.55M
    -$5.08M
    -$6.28M
    -26.6%
    $4.56M
    -$4.32M
    +5.0%
    -$524.0K
    +89.7%
    Strengthening
    Net Profit
    -$5.67M
    -$1.40M
    -$4.20M
    -$5.32M
    -$6.65M
    -17.3%
    $5.64M
    -$4.75M
    -13.1%
    -$604.0K
    +88.7%
    Strengthening
    EPS
    $-0.98
    $-0.47
    $-0.57
    $-0.62
    +36.7%
    $-0.41
    +12.8%
    $-0.05
    +91.2%
    Strengthening
    Other Income
    -$706.0K
    $314.0K
    $343.0K
    -$224.0K
    -$365.0K
    +48.3%
    $1.08M
    +244.9%
    -$432.0K
    -225.9%
    -$57.0K
    +74.6%
    Strengthening
    Interest
    $120.0K
    Depreciation
    Profit before Tax
    -$5.67M
    -$1.40M
    -$4.20M
    -$5.30M
    -$6.64M
    -17.2%
    $5.64M
    -$4.75M
    -13.0%
    -$581.0K
    +89.0%
    Strengthening
    MarginsOPM
    -55.0%
    -13.6%
    -53.0%
    -56.3%
    -89.8%
    -63.2%
    26.6%
    -42.8%
    +19.1%
    -4.4%
    +92.2%
    Strengthening
    Tax
    -0.1%
    0.1%
    0.0%
    -0.4%
    -0.1%
    -80.0%
    -0.0%
    -114.3%
    -4.0%
    -890.0%
    Weakening
    ReturnsROIC
    4.3%
    1.0%
    3.2%
    4.0%
    5.0%
    +17.3%
    -4.2%
    -504.0%
    3.6%
    +13.1%
    0.5%
    -88.7%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$8.08M$24.55M$17.21M$1.34M$5.91M$6.39M$4.66M
    Short-Term Investments
    Total Current Assets$19.58M$46.42M$43.14M$23.07M$20.70M$18.08M$12.44M
    Net PP&E$370.0K$267.0K$1.58M$1.75M$983.0K$3.74M$4.95M
    Goodwill
    Intangibles$3.87M$3.45M$3.03M$2.63M$35.0K$2.65M$2.57M
    Total Assets$24.14M$53.22M$50.88M$27.93M$22.10M$28.56M$24.06M
    LiabilitiesTotal Current Liabilities$4.42M$13.84M$20.89M$18.09M$12.02M$11.89M$10.54M
    Short-Term Debt$3.90M
    Long-Term Debt
    Long-Term Leases$848.0K$804.0K$276.0K$1.24M$2.41M
    Total Liabilities$18.31M$41.88M$27.01M$23.14M$17.67M$18.08M$18.11M
    EquityCommon Stock & APIC$8.0K$17.0K$1.0K$2.0K$9.0K$12.0K$14.0K
    Retained Earnings-$41.17M-$78.88M-$79.52M-$99.65M-$117.41M-$127.94M-$133.30M
    Total Equity$5.83M$11.34M$23.88M$4.79M$4.43M$10.48M$5.96M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$12.37M-$26.71M-$16.20M-$24.89M-$10.27M-$13.36M-$7.93M
    Cash from Investing-$11.0K-$5.16M$619.0K-$3.0K$3.00M$3.00M
    Cash from Financing$13.19M$43.19M$14.02M$8.41M$14.84M$10.85M
    SummaryCapital Expenditure-$38.0K-$5.0K-$10.0K-$2.0K-$3.0K
    Free Cash Flow-$16.24M-$24.90M-$10.28M-$13.36M-$7.93M
    FCF Margin-56.6%-73.1%-27.5%-32.0%-17.2%

    Ratios